本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Apellis Pharmaceuticals Inc.

20.96
-0.6800-3.14%
盤後20.960.00000.00%19:55 EST
成交量:187.41萬
成交額:3,931.68萬
市值:26.79億
市盈率:121.57
高:21.30
開:21.30
低:20.79
收:21.64
52周最高:30.48
52周最低:16.10
股本:1.28億
流通股本:7,811.99萬
量比:0.76
換手率:2.40%
股息:- -
股息率:- -
每股收益(TTM):0.1724
每股收益(LYR):0.1724
淨資產收益率:7.48%
總資產收益率:3.53%
市淨率:7.24
市盈率(LYR):121.57

資料載入中...

2025/01/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities